

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+5.62%
-2.32%
-3.26%
+11.01%
+11.27%
PALI
Palisade Bio Inc.
$1.77
Chart
$0.9 (+96.67%)
$1.05 (+68.57%)
$0.74 (+139.19%)
$2.58 (-31.40%)
PALI has High Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Price under $5

High volatilty

PALI overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future
![]()
PALI Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
PALI Street view is extremely bullish and have negative views on the near-term outlook
Average key support and resistance price levels.
Login to displayWhat is PALI current stock price?
What are PALI stock strengths?
What risks are associated with PALI stock?
When is PALI next earnings report?
What is PALI market cap and volume?
What is PALI's current Stock IQ?
Should I buy PALI stock right now?
Is PALI a Strong Buy right now?
What does a 'Strong Buy' rating mean for PALI?
What does a 'Strong Sell' rating mean for PALI?
What factors influence PALI's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+5.62%
-2.32%
-3.26%
+11.01%
+11.27%
PALI
Palisade Bio Inc.
Current Price
$1.77
Chart
$0.9 (+96.67%)
$1.05 (+68.57%)
$0.74 (+139.19%)
$2.58 (-31.40%)
PALI Analysts Opinion
PALI Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future
![]()
PALI Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
PALI Street view is extremely bullish and have negative views on the near-term outlook
PALI has High Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Price under $5

High volatilty

Average key support and resistance price levels.
PALI Latest Analysis
Palisade Bio Granted Canadian Patent Covering Composition of Lead Product Candidate PALI-2108 . PALI-2108 is the first and only PDE4 inhibitor designed to target terminal ileum and colon for fibrostenotic Crohns disease (FSCD) and ulcerative colitis (UC) to address significant unmet medical needs
Mon Oct 13, 2025
Biotech Stocks Surge After Hours: PCSA PALI And QTTB Lead On Volume And Speculation . (RTTNews) - Several small-cap biotech stocks posted sharp gains in after-hours trading on Tuesday driven by speculative momentum recent clinical updates and capital market activity. Heres a look at the most notable movers including Processa Pharmaceuticals Palisade Bio and
Wed Oct 8, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
PALI Stock trends
PALI Stock performance
PALI Stock analysis
PALI investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.